Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS
| Hlavní autoři: | , , , , , , , , , , , , |
|---|---|
| Médium: | Journal article |
| Vydáno: |
2009
|
| _version_ | 1826268998583451648 |
|---|---|
| author | Jones, R Tervaert, J Hauser, T Luqmani, R Peh, C Savage, C Segelmark, M Tesar, V Van Paassen, P Walsh, M Walsh, D Westman, K Jayne, D |
| author_facet | Jones, R Tervaert, J Hauser, T Luqmani, R Peh, C Savage, C Segelmark, M Tesar, V Van Paassen, P Walsh, M Walsh, D Westman, K Jayne, D |
| author_sort | Jones, R |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T21:18:09Z |
| format | Journal article |
| id | oxford-uuid:40820f70-7197-4c5c-bfd2-9f6876e41637 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T21:18:09Z |
| publishDate | 2009 |
| record_format | dspace |
| spelling | oxford-uuid:40820f70-7197-4c5c-bfd2-9f6876e416372022-03-26T14:38:20ZRandomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVASJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:40820f70-7197-4c5c-bfd2-9f6876e41637Symplectic Elements at Oxford2009Jones, RTervaert, JHauser, TLuqmani, RPeh, CSavage, CSegelmark, MTesar, VVan Paassen, PWalsh, MWalsh, DWestman, KJayne, D |
| spellingShingle | Jones, R Tervaert, J Hauser, T Luqmani, R Peh, C Savage, C Segelmark, M Tesar, V Van Paassen, P Walsh, M Walsh, D Westman, K Jayne, D Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS |
| title | Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS |
| title_full | Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS |
| title_fullStr | Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS |
| title_full_unstemmed | Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS |
| title_short | Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS |
| title_sort | randomized trial of rituximab vs cyclophosphamide for anca associated renal vasculitis rituxvas |
| work_keys_str_mv | AT jonesr randomizedtrialofrituximabvscyclophosphamideforancaassociatedrenalvasculitisrituxvas AT tervaertj randomizedtrialofrituximabvscyclophosphamideforancaassociatedrenalvasculitisrituxvas AT hausert randomizedtrialofrituximabvscyclophosphamideforancaassociatedrenalvasculitisrituxvas AT luqmanir randomizedtrialofrituximabvscyclophosphamideforancaassociatedrenalvasculitisrituxvas AT pehc randomizedtrialofrituximabvscyclophosphamideforancaassociatedrenalvasculitisrituxvas AT savagec randomizedtrialofrituximabvscyclophosphamideforancaassociatedrenalvasculitisrituxvas AT segelmarkm randomizedtrialofrituximabvscyclophosphamideforancaassociatedrenalvasculitisrituxvas AT tesarv randomizedtrialofrituximabvscyclophosphamideforancaassociatedrenalvasculitisrituxvas AT vanpaassenp randomizedtrialofrituximabvscyclophosphamideforancaassociatedrenalvasculitisrituxvas AT walshm randomizedtrialofrituximabvscyclophosphamideforancaassociatedrenalvasculitisrituxvas AT walshd randomizedtrialofrituximabvscyclophosphamideforancaassociatedrenalvasculitisrituxvas AT westmank randomizedtrialofrituximabvscyclophosphamideforancaassociatedrenalvasculitisrituxvas AT jayned randomizedtrialofrituximabvscyclophosphamideforancaassociatedrenalvasculitisrituxvas |